CATALOGO DEI PRODOTTI DELLA RICERCA

MICHELETTO, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.192
NA - Nord America 1.094
AS - Asia 751
SA - Sud America 94
AF - Africa 26
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.161
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.080
GB - Regno Unito 339
SG - Singapore 309
CN - Cina 300
IT - Italia 285
SE - Svezia 99
RU - Federazione Russa 91
BR - Brasile 86
FR - Francia 86
IE - Irlanda 76
DE - Germania 74
FI - Finlandia 50
HK - Hong Kong 34
PL - Polonia 27
KR - Corea 26
JP - Giappone 25
UA - Ucraina 16
ZA - Sudafrica 14
BE - Belgio 12
ID - Indonesia 12
CA - Canada 11
IN - India 9
NL - Olanda 8
AT - Austria 7
MY - Malesia 7
TG - Togo 6
VN - Vietnam 6
SA - Arabia Saudita 5
TR - Turchia 5
CZ - Repubblica Ceca 4
LT - Lituania 4
AR - Argentina 3
AZ - Azerbaigian 3
CH - Svizzera 3
ES - Italia 3
MA - Marocco 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BG - Bulgaria 2
EC - Ecuador 2
HU - Ungheria 2
MX - Messico 2
PK - Pakistan 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
UZ - Uzbekistan 1
Totale 3.161
Salva come PNG Salva come JPEG
Città #
Southend 280
Chandler 226
Singapore 163
Jacksonville 125
Ashburn 82
Dublin 76
Redmond 69
Verona 65
Ann Arbor 59
Beijing 52
Houston 43
Woodbridge 41
New York 39
Lawrence 32
Princeton 32
Hong Kong 31
Boardman 27
Milan 26
Jinan 25
Wilmington 25
Helsinki 22
Sindelfingen 21
Rome 19
Tokyo 19
Changsha 18
Shenyang 16
Nanjing 15
Bologna 14
Naples 13
Ningbo 13
Jakarta 12
Taizhou 12
The Dalles 11
Zhengzhou 11
Brussels 10
Pretoria 10
Seattle 10
Tianjin 10
Hebei 9
Dallas 8
Falls Church 8
Haikou 8
Lanzhou 8
Kuala Lumpur 7
London 7
Taiyuan 7
Toronto 7
City of Westminster 6
Fuzhou 6
Jiaxing 6
Kent 6
Lomé 6
Nuremberg 6
São Paulo 6
Auburn Hills 5
Chicago 5
Frankfurt am Main 5
Hangzhou 5
Lancaster 5
Los Angeles 5
Munich 5
Norwalk 5
Palermo 5
Redwood City 5
Rio de Janeiro 5
Ancona 4
Boydton 4
Brescia 4
Brno 4
Delhi 4
Dongguan 4
Lozzo Atestino 4
Seoul 4
Turin 4
Warsaw 4
Baku 3
Bolzano 3
Catania 3
Düsseldorf 3
Guangzhou 3
Johannesburg 3
Lima 3
Menlo Park 3
Moscow 3
Nanchang 3
Negrar 3
Ottawa 3
Riyadh 3
Salvador 3
Santa Clara 3
Shanghai 3
Vienna 3
Abbiategrasso 2
Acquedolci 2
Altopascio 2
Bari 2
Barnet 2
Belém 2
Bonsecours 2
Chennai 2
Totale 2.047
Salva come PNG Salva come JPEG
Nome #
Cost analysis of GER-induced asthma: a controlled study vs. atopic asthma of comparable severity. 258
Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management 256
A two-stage logistic Model Based on the Measurament of Pro-Infectious Cytokines in Bronchial Secretions for Assessing Bacterial, Viral and Non-Infectious Origin of COPD Exacerbation - Original Research 122
A MCh test pre-post esophageal acidification in detecting GER-related asthma. 116
Assessment of COVID-19 progression on day 5 from symptoms onset 109
Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. 102
Lung metastasis from TTF-1 positive sigmoid adenocarcinoma. pitfalls and management. 96
Effect of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma 92
Diagnostic management of occult nodal lymphangioleiomyomatosis detected during pelvic cancer staging. Localized finding or systemic disease? 92
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 92
Asthmatic patients in COVID-19 outbreak: Few cases despite many cases 91
PIKO-1, an effective, handy device for the patient's personal PEFR and FEV1 electronic long-term monitoring. 89
Reference urinary LTE4 levels in normal individuals: a pilot study. 88
PATTERN OF AIRWAY INFLAMMATION AND REMODELLING IN MILD PERSISTENT ATOPIC ASTHMA AND IN MILD PERSISTENT ASTHMA RELATED TO GASTROESOPHAGEAL REFLUX 86
Changes in total IgE plasma concentration measured at the third month during anti-IgE treatment predict future exacerbation rates in difficult-to-treat atopic asthma: a pilot study. 83
Determinants of Persistence of Symptoms and Impact on Physical and Mental Wellbeing in Long COVID: A Prospective Cohort Study 83
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 80
Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma. 77
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 77
Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity 77
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 77
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 76
Omalizumab management beyond clinical trials: the added value of a network model 71
Low adherence to inhaled corticosteroids/long-acting β2-agonists and biologic treatment in severe asthmatics 70
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 69
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 62
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 61
Nasal and Bronchial Tolerability of Rofecoxib in Patients with Aspirin induced Asthma 60
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase 60
Mepolizumab for severe eosinophilic asthma: a real-world snapshot on clinical markers and timing of response 54
Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease 52
Multidisciplinary management in type 2 inflammatory disease 49
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 44
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times 41
Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a cross-sectional study protocol 36
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 35
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 30
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" 28
Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy 24
Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence 21
Profiling blood hypereosinophilia in patients on dupilumab treatment for respiratory conditions: a real-life snapshot 17
Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study 8
CT radiomic models to distinguish COVID-19 pneumonia from other interstitial pneumonias 7
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 7
Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma 5
Totale 3.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.316
article - articoli 12.316
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.632
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202073 0 0 0 0 0 0 0 0 0 17 37 19
2020/2021327 82 41 4 34 30 31 19 12 20 19 29 6
2021/2022366 52 113 12 22 8 9 5 22 13 8 25 77
2022/2023628 39 71 56 110 64 120 7 33 73 6 30 19
2023/2024497 27 38 47 47 45 78 26 36 12 28 77 36
2024/2025840 78 59 48 158 50 48 83 82 185 49 0 0
Totale 3.230